IGM Biosciences, Inc. Rings the Opening Bell in Celebration of its IPO

Name: IGM Biosciences, Inc. Rings the Opening Bell in Celebration of its IPO
Start: 2019-09-18T13:00:00
End: 2019-09-18T13:45:00
Location: 4 Times SquareNew York, NYUnited States

September 18, 2019 — 9:00 AM - 9:45 AM ET

Nasdaq MarketSite, 4 Times Square, New York

ABOUT THIS EVENT

IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, the below members of the IGM team rang the Opening Bell:

Fred Schwarzer, Chief Executive Officer
Bruce Keyt, Chief Scientific Officer
Jakob Topsøe, Director
Christina Topsøe, Director
Nelson Teng, Scientific Founder

My Quotes
My European Quotes
Watchlist

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.

View as Table

now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Shares, Indexes, ETP and more asset classes.

Edit Watchlist

Your Watchlist is empty.

Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.